Health
PET/CT insights predict immunotherapy response in patients with advanced lung cancer – Health Imaging
Checkpoint inhibitors target the PD-L1/PD1 signaling pathway and are commonly used to treat those with NSCLC. While this therapy can be highly effective, it only works for nearly 50% of patients.
In order to avoid treating those who likely wont respond,…
Continue Reading
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News20 hours agoMissing man, Maroochydore – Queensland Police News
-
General18 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz